AlphaProteo

Benefit

+1.22

Harm

0.00

Net Good

1.22

Verified benefit

1.22

History

Cumulative score

Benefit
Harm
Net

Domains

Biology1.22

Release

Status released. First dated 5 Sep 2024.

Event timeline

Benefit5 Sep 2024

AlphaProteo designs experimentally validated high-affinity protein binders

DeepMind’s AlphaProteo, released 5 September 2024, produced binders to seven targets with higher experimental success and affinities than prior computational methods; Crick Institute labs confirmed SARS-CoV-2 and VEGF-A functions.

BiologyverifiedTier 3 Major+1.22